Skip to main content
Fig. 4 | Clinical Epigenetics

Fig. 4

From: Tissue of origin prediction for cancer of unknown primary using a targeted methylation sequencing panel

Fig. 4

Examples of highly informative hyper- (A–E) and hypo- (F–H) methylation markers for specific cancer types. Mean methylation (β value) across 23 cancer types and the corresponding normal tissue were shown. ACC Adrenocortical carcinoma, BLCA Bladder urothelial carcinoma, BRCA Breast invasive carcinoma, CESC Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD Colon adenocarcinoma, LAML Acute myeloid leukemia, LIHC Liver hepatocellular carcinoma, LUAD Lung adenocarcinoma, LUSC Lung squamous cell carcinoma, MESO Mesothelioma, PAAD Pancreatic adenocarcinoma, PCPG Pheochromocytoma and paraganglioma, PRAD Prostate adenocarcinoma, SARC Sarcoma, SKCM Skin cutaneous melanoma, STAD Stomach adenocarcinoma, TGCT Testicular germ cell tumors, THCA Thyroid carcinoma, UCEC Uterine corpus endometrial carcinoma, UVM Uveal melanoma

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us